Profile
Dr Esmeralda Teo was educated in the UK and graduated from Imperial College School of Medicine. She did her foundation training in the North London Deanery and her Internal Medicine training in Singapore General Hospital. She completed her fellowship in Haematology with a special interest in Acute Leukaemia and Cancer Survivorship.
Dr Teo was awarded the NRMC clinician scientist award to investigate the interplay of synergistic mechanisms in combination chemotherapy for lymphoma and myeloma at the MD Anderson Cancer Centre in Houston, United States. She has publications in several peer-reviewed journals. During this time, she also completed a chaplaincy course and was awarded the lay chaplain of the year award.
Dr Teo completed a Graduate Diploma in Palliative Care and uses that training to bring to the forefront an integrated supportive care approach in the initial management and diagnosis of leukemias. She believes in the holistic approach to the management of haematological conditions and places a strong emphasis on a multi-disciplinary care, maximizing social support and integration of new evidence-based treatment, to ensure that patients receive good individualized care.
Education
- GDip (Pall Med) (2020)
- FAMS (2017)
- MRCP (UK) (2011)
- AICSM (2007)
- MBBS (2007)
- BSc (2005)
View More +
Professional Appointments and Committee Memberships
- Assistant Professor Duke/NUS
- Member of Ethics Committee
- Core Faculty Member for Singhealth Internal Medicine
- Treasurer of the Singapore Society of Haematology
View More +
Awards
- Heart of Gold Award (2016)
- Reverend Dr Lawrence W Johnson Award Lay Chaplain of the Year - MD Anderson Cancer Centre, Houston, Texas (2015)
- NMRC Clinical Scientist Award (2014)
- Gold Service Award (2014)
- Silver Service Award (2012)
View More +
Publications
- Teo EC, Tan BH, Purdy MA, Wong PS, Ting PJ, Chang PJ, Oon LL, Sue A, Teo CG, Tan CK. Hepatitis E in Singapore: A Case-Series and Viral Phylodynamics Study. Am J Trop Med Hyg. 2017 Apr;96(4):922-928
- Yeap WH, Kok LW, Shimasaki N, Teo EC, Quek J et al. CD16 is indispensable for antibody-dependent cellular cytoxicity by human monocytes. Sco Rep.2016. Sep 27;6:34310.
- Teo EC and Phipps C. Monoclonal antibodies in lymphoma. P256-299. Frontiers in clinical drug research. Ebook Chapter. DOI: 10.2174/97816810818161160201
- Valdez BC, Brammer JE, Li Y, Murray D, Teo EC, Liu Y, Hosing C, Nieto Y, Champlin R, Andersson BS. Romidepsin enhances the cytotoxicity of fludarabine, clofarabin and busulfan combination in malignant T cells. Leuk res 2016 Aug;47:100-108
- Teo EC, Valdez BC; Ji J, Liu Y, Liu Y, Brammer JE, Hosing C, Nieto Y, Champlin RE, Andersson BS. Synergistic cytotoxicity of busulfan, melphalan, gemcitabine, panobinostat and bortezomib in lymphoma cells. Leukemia & lymphoma: 1-9,2016
- Ji Jie, Valdez BC, Li Y, Liu Y, Teo EC, Nieto Y, Champlin R, Andersson BS. Cladribine, gemcitabine, busulfan and SAHA combination as a potential pretransplant conditioning regime for lymphomas: a pre clinical study. Exp Hematol. 2016 Jun;44(6)458-65
- Teo EC, Chew Y, Diong C. A review of monoclonal antibody therapies in lymphoma. Crit Rev Oncol Haematol. 2016 Jan;97:72-84
- Lee GH, Tan BH, Teo EC, Lim SG, Dan YY, Wee A, Aw PP, Zhu Y, Hibberd ML, Tan CK, Purdy MA, Teo CG. Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk. Gastroenterology. 2016 Feb;150(2):355-7.e3
- Ng HJ, Than H, Teo EC. First experiences with the use of Rivaroxaban in the treatment of heparin-induced thrombocytopenia. Thromb Res. 2015 Jan;135(1):205-7.
- Contributed lectures in Polycythaemia and Myelodysplastic Sydrome, in the Voice Annotated Digital Lecture Series in Haematology for Duke Medical School, Singapore
- Teo EC, Azwa A, Jones R et al. Guillain Barré Syndrome following immune reconstitution after antiretroviral therapy for primary HIV infection. J HIV Therapy, 2007, 12, (3) Case Report
View More +
